---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-25-000053"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T11:46:18.673294+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health raises FY25 EPS guidance to $8.15-$8.20; sets FY26 preliminary EPS $9.10-$9.30

## Summary
- Raising FY25 non-GAAP diluted EPS to $8.15-$8.20 (from $8.05-$8.15); 9% growth at midpoint.
- Preliminary FY26 non-GAAP diluted EPS $9.10-$9.30 (+13% growth); adjusted FCF $2.75B-$3.25B.
- Long-term FY26-FY28: 12-14% EPS CAGR; at least $10B total adjusted FCF; buybacks raised to $750M/year.
- Launched The Specialty Alliance (GI Alliance, Urology Alliance); expanding Biopharma Solutions; new distribution center planned.
- GMPD long-term target: $50M+ profit growth/year after FY26; FY25 GMPD profit narrowed to ~$130M.

## SEC filing metadata
- accession: 0000721371-25-000053
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137125000053/0000721371-25-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000053/cah-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-25-000053
- JSON: https://secwatch.observer/filing/0000721371-25-000053.json
- Plain text: https://secwatch.observer/filing/0000721371-25-000053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.